Heart Failure: Entresto is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction.
Entresto is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other ARB.
Hypertension: Entresto is indicated for the treatment of essential hypertension.